Alpha 2.0
Login Register
» Authors » Marcus Green

Marcus Green

Explore the profile of Marcus Green including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 358
Followers 0
Related Specialties
General Medicine
Gynecology & Obstetrics
Orthopedics
Top 10 Co-Authors
Lucy C Chappell
Richard J McManus
Paul T Seed
Jane Sandall
Andrew H Shennan
Jenny Myers
Cheryl Battersby
Jenie Sparkes
Carole Crawford
Pollyanna Hardy
Published In
BMJ
BMJ Open
Pregnancy Hypertens
Trials
BJOG
Affiliations
Soon will be listed here.
Recent Articles
1.
Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study
Elbarbary N, Wang C, Ganapathy R, Green M, Fisher S, Thilaganathan B, et al.
BMJ Open . 2025 Feb; 15(1):e093586. PMID: 39894517
Introduction: Pre-eclampsia is a condition associated with significant maternal and neonatal morbidity and mortality. The prediction of pre-eclampsia in high-risk populations using angiogenic markers, such as serum placental growth factor...
2.
Self-monitoring blood pressure in pregnancy: evaluation of women's experiences of the BUMP trials
Chisholm A, Tucker K, Crawford C, Green M, Greenfield S, Hodgkinson J, et al.
BMC Pregnancy Childbirth . 2024 Nov; 24(1):800. PMID: 39604875
Background: The COVID-19 pandemic accelerated the adoption of remote care, or telemedicine, in many clinical areas including maternity care. One component of remote care, the use of self-monitoring of blood...
3.
Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial
Magee L, Kirkham K, Tohill S, Gkini E, Moakes C, Dorling J, et al.
PLoS Med . 2024 Nov; 21(11):e1004481. PMID: 39591427
Background: Chronic or gestational hypertension complicates approximately 7% of pregnancies, half of which reach 37 weeks' gestation. Early term birth (at 37 to 38 weeks) may reduce maternal complications, cesareans,...
4.
Repeat Placental Growth Factor-Based Testing in Women With Suspected Preterm Preeclampsia: A Stratified Analysis of the PARROT-2 Trial
Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, et al.
Hypertension . 2024 May; 81(7):1561-1573. PMID: 38708607
Background: PlGF (placental growth factor)-based testing reduces severe maternal adverse outcomes. Repeat PlGF-based testing is not associated with improved perinatal or maternal outcomes. This planned secondary analysis aimed to determine...
5.
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial
Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, et al.
Lancet . 2024 Feb; 403(10427):619-631. PMID: 38342128
Background: Placental growth factor (PlGF)-based testing has high diagnostic accuracy for predicting pre-eclampsia needing delivery, significantly reducing time to diagnosis and severe maternal adverse outcomes. The clinical benefit of repeat...
6.
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials
Chisholm A, Tucker K, Crawford C, Green M, Greenfield S, Hodgkinson J, et al.
Pregnancy Hypertens . 2024 Feb; 35:88-95. PMID: 38301352
Background: The BUMP trials evaluated a self-monitoring of blood pressure intervention in addition to usual care, testing whether they improved detection or control of hypertension for women at risk of...
7.
Detection and Control of Pregnancy Hypertension Using Self-Monitoring of Blood Pressure With Automated Telemonitoring: Cost Analyses of the BUMP Randomized Trials
Campbell H, Chappell L, McManus R, Tucker K, Crawford C, Green M, et al.
Hypertension . 2024 Jan; 81(4):887-896. PMID: 38258566
Background: Pregnancy hypertension continues to cause maternal and perinatal morbidity. Two linked UK randomized trials showed adding self-monitoring of blood pressure (SMBP) with automated telemonitoring to usual antenatal care did...
8.
Using self-monitoring to detect and manage raised blood pressure and pre-eclampsia during pregnancy: the BUMP research programme and its impact
Tucker K, Hinton L, Green M, Chappell L, McManus R
Hypertens Res . 2023 Dec; 47(3):714-720. PMID: 38062200
Raised blood pressure affects around ten percent of pregnancies worldwide, causing maternal and perinatal morbidity and mortality. Self-monitoring of blood pressure during higher-risk or hypertensive pregnancy has been shown to...
9.
A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA)
Ashworth D, Battersby C, Bick D, Green M, Hardy P, Leighton L, et al.
Trials . 2023 Sep; 24(1):584. PMID: 37700365
Background: Approximately one in ten women have high blood pressure during pregnancy. Hypertension is associated with adverse maternal and perinatal outcomes, and as treatment improves maternal outcomes, antihypertensive treatment is...
10.
Hypertensive disorders of pregnancy
Wu P, Green M, Myers J
BMJ . 2023 Jun; 381:e071653. PMID: 37391211
Hypertensive disorders of pregnancy (HDP) are one of the most commonly occurring complications of pregnancy and include chronic hypertension, gestational hypertension, and pre-eclampsia. New developments in early pregnancy screening to...